Provided by Tiger Trade Technology Pte. Ltd.

Tempest Therapeutics Inc.

1.12
+0.364748.28%
Volume:93.34M
Turnover:109.62M
Market Cap:18.53M
PE:-0.25
High:1.48
Open:1.07
Low:0.9675
Close:0.7554
52wk High:12.23
52wk Low:0.7432
Shares:16.54M
Float Shares:11.46M
Volume Ratio:18.34
T/O Rate:814.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.5617
EPS(LYR):-19.4955
ROE:-931.14%
ROA:-79.37%
PB:-17.00
PE(LYR):-0.06

Loading ...

Tempest Announces Development Collaboration with Senlang Biotechnology for Tpst-4003, a Cd7-targeted Next-generation in Vivo CAR-T

THOMSON REUTERS
·
Jul 21

Tempest Therapeutics - Co and Senlang to Develop Tpst-4003 with Trial in China for Mg and MS

THOMSON REUTERS
·
Jul 21

Tempest Therapeutics - First Patient Dosing for Tpst-4003 Trial Expected in Q4 2026

THOMSON REUTERS
·
Jul 21

How Jakarta Plans to End Open Dumping in Bantargebang

Tempo
·
Jul 18

Tempest Therapeutics Plans First Clinical Study of in Vivo CAR-T Candidate Tpst-4003 in Q4 2026

Reuters
·
Jul 15

Rani Therapeutics Names Nicholas Maestas CFO, Replacing Svai Sanford

Reuters
·
Jun 29

Tempest Therapeutics Registers 2.43 Million Shares for Resale

MT Newswires Live
·
Jun 27

Tempest Therapeutics - Selling Stockholders May Offer up to 2.43 Mln Shares of Tempest Therapeutics Common Stock - SEC Filing

THOMSON REUTERS
·
Jun 27

Jakarta Offers Prizes for Waste Sorting on Anniversary Peak Night

Tempo
·
Jun 25

Tempest Therapeutics CEO Matthew Angel reports indirect purchase of 231,482 shares for $499,999.12

Reuters
·
Jun 24

Tempest Therapeutics shareholders approved Nasdaq Rule 5635 share issuances at special meeting

Reuters
·
Jun 23

Tempest Therapeutics director John D. Yee files initial beneficial ownership statement

Reuters
·
Jun 18

Tempest Therapeutics director William Drake Richey files initial beneficial ownership statement

Reuters
·
Jun 09

Tempest Therapeutics - Nicholas Maestas Resigns as CFO Effective June 5, 2026 - SEC Filing

THOMSON REUTERS
·
Jun 05

Tempest Therapeutics adds Drake Richey, John Yee to board

Reuters
·
Jun 05

Tempest Therapeutics Appoints Drake Richey and John Yee, Md, Mph to Board of Directors

THOMSON REUTERS
·
Jun 05

Tempest Therapeutics issues unregistered warrant for up to 2,344,828 shares in inducement deal

Reuters
·
Jun 02

Tempest Therapeutics director Simantov resigns from board

Reuters
·
May 30

Tempest Therapeutics announces exercise of 1,172,414 warrants at reduced $1.73 per share price

Reuters
·
May 29

Tempest Therapeutics gets Nasdaq notice for failing $2.5 million equity rule

Reuters
·
May 23